What is the best way to predict disease-free survival after preoperative radio chemotherapy for rectal cancer patients:: Tumor regression grading, nodal status, or circumferential resection margin invasion?: Reply

被引：1
|
作者：
Rödel, C [1 ]
Sauer, R [1 ]
机构：
[1] Univ Erlangen Nurnberg, Dept Radiat Therapy, Erlangen, Germany
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2006年 / 24卷 / 08期
关键词：
D O I：
10.1200/JCO.2005.05.1557
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1320 / 1320
页数：1
相关论文
共 15 条
  • [11] Correlation of tumor regression grade (TRG), circumferential margin (CM), and epidermal growth factor receptor expression with disease-free survival (DFS) in locally advanced rectal cancer patients (LARC) treated with preoperative radiochemotherapy (preCh-RT).
    Arias, F.
    Guerrero, D.
    Gomez Dorronsoro, M. L.
    Montes, M.
    Vera, R.
    Asin, G.
    Monzon, F.
    Balen, E.
    Armendariz, P.
    Vila, M.
    Chicata, V.
    Viudez, A.
    Bandres, E.
    Garcia-Foncillas, J.
    DomAnguez, M. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [12] Prognostic Factors for Disease-Free Survival after Preoperative Chemotherapy Followed by Curative Resection in Patients with Colorectal Cancer Harboring Hepatic Metastasis: A Single-Institute, Retrospective Analysis in Asia
    Yi, Jun Ho
    Kim, Hyunki
    Jung, Minkyu
    Shin, Sang Joon
    Choi, Jin Sub
    Choi, Gi-Hong
    Baik, Seung Hyuk
    Min, Byung Soh
    Kim, Nam Kyu
    Ahn, Joong Bae
    ONCOLOGY, 2013, 85 (05) : 283 - 289
  • [13] Tumor regression grading after preoperative chemoradiotherapy as prognostic factor and individual-level surrogate for disease-free survival in rectal cancer: Results of the CAO/ARO/AIO-04 multicentre, open-label, randomised, phase 3 trial
    Fokas, E.
    Stroebel, P.
    Fietkau, R.
    Ghadimi, M.
    Liersch, T.
    Grabenbauer, G.
    Hartmann, A.
    Kaufmann, M.
    Sauer, R.
    Graeven, U.
    Hoffmanns, H.
    Raab, H-R
    Hothorn, T.
    Wittekind, C.
    Roedel, C.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2017, 193 : S31 - S31
  • [14] Genetic variations in the PI3K/PTEN/AKT/mTOR pathway predict tumor response and disease-free survival in locally advanced rectal cancer patients receiving preoperative chemoradiotherapy and radical surgery
    Peng, Jianhong
    Ma, Wenjuan
    Zhou, Zhongguo
    Gu, Yangkui
    Lu, Zhenhai
    Zhang, Rongxin
    Pan, Zhizhong
    JOURNAL OF CANCER, 2018, 9 (06): : 1067 - 1077
  • [15] Adjuvant chemotherapy with oxaliplatin/5-fluorouracil/leucovorin (FOLFOX) versus 5-fluorouracil/leucovorin (FL) for rectal cancer patients whose postoperative yp stage 2 or 3 after preoperative chemoradiotherapy: Updated results of 3-year disease-free survival from a randomized phase II study (The ADORE).
    Hong, Yong Sang
    Nam, Byung-Ho
    Kim, Kyu-Pyo
    Lee, Jae-Lyun
    Park, Joon Oh
    Park, Young Suk
    Kim, Sun Young
    Kim, Tae-You
    Kim, Jee Hyun
    Ahn, Joong Bae
    Jung, Kyung Hae
    Kim, Tae Won
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
12